Home
About
FAQ
History (5)
Development of a novel therapeutic agent that exploits specific vulnerabilities in claudin low breast cancer
Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells.
Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction.
Regulatable promoters for use in gene therapy applications: modification of the 5'-flanking region of the CFTR gene with multiple cAMP response elements to support basal, low-level gene expression that can be upregulated by exogenous agents that raise intracellular levels of cAMP.
Small bowel obstruction after hysterectomy to treat benign disease.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction.
Peters AE, DeVore AD. Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction. Cardiol Clin. 2022 Nov; 40(4):473-489.
View in:
PubMed
subject areas
Diabetes Mellitus, Type 2
Glucose
Heart Failure
Humans
Neprilysin
Receptors, Angiotensin
Sodium
Stroke Volume
Ventricular Function, Left
authors with profiles
Anthony E. Peters MD, MS